These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

813 related items for PubMed ID: 17711899

  • 1. Antiphospholipid antibodies in pediatric systemic lupus erythematosus and the antiphospholipid syndrome.
    Avcin T, Silverman ED.
    Lupus; 2007; 16(8):627-33. PubMed ID: 17711899
    [Abstract] [Full Text] [Related]

  • 2. Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome.
    Tektonidou MG, Sotsiou F, Nakopoulou L, Vlachoyiannopoulos PG, Moutsopoulos HM.
    Arthritis Rheum; 2004 Aug; 50(8):2569-79. PubMed ID: 15334471
    [Abstract] [Full Text] [Related]

  • 3. Anti-heparin platelet factor 4 antibodies in systemic lupus erythematosus are associated with IgM antiphospholipid antibodies and the antiphospholipid syndrome.
    Alpert D, Mandl LA, Erkan D, Yin W, Peerschke EI, Salmon JE.
    Ann Rheum Dis; 2008 Mar; 67(3):395-401. PubMed ID: 17644539
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Leiden, G20210A mutations in prothrombin gene and antiphospholipid antibodies in systemic lupus erythematosus and antiphospholipid syndrome].
    Reshetniak TM, Patrushev LI, Stukacheva EA, Miroshnikov AI, Tikhonova TL, Nasonov EL, Alekberova ZS.
    Ter Arkh; 2000 Mar; 72(5):34-8. PubMed ID: 11109617
    [Abstract] [Full Text] [Related]

  • 6. Prevalence and clinical significance of antiprothrombin antibodies in patients with systemic lupus erythematosus or with primary antiphospholipid syndrome.
    Muñoz-Rodríguez FJ, Reverter JC, Font J, Tàssies D, Cervera R, Espinosa G, Carmona F, Balasch J, Ordinas A, Ingelmo M.
    Haematologica; 2000 Jun; 85(6):632-7. PubMed ID: 10870121
    [Abstract] [Full Text] [Related]

  • 7. Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus.
    Danowski A, de Azevedo MN, de Souza Papi JA, Petri M.
    J Rheumatol; 2009 Jun; 36(6):1195-9. PubMed ID: 19447935
    [Abstract] [Full Text] [Related]

  • 8. Longitudinal determination of antiphospholipid antibodies in lupus patients without previous manifestations of antiphospholipid syndrome. A prospective study.
    de Bandt M, Benali K, Guillevin L, Hachulla E, Job C, Fautrel B, Fournié G, Bonnet C, Fournié B, Le Goff P, Jorgensen C, Meyer O.
    J Rheumatol; 1999 Jan; 26(1):91-6. PubMed ID: 9918247
    [Abstract] [Full Text] [Related]

  • 9. Ocular manifestations in antiphospholipid syndrome.
    Suvajac G, Stojanovich L, Milenkovich S.
    Autoimmun Rev; 2007 Jun; 6(6):409-14. PubMed ID: 17537387
    [Abstract] [Full Text] [Related]

  • 10. The geoepidemiology of the antiphospholipid antibody syndrome.
    Biggioggero M, Meroni PL.
    Autoimmun Rev; 2010 Mar; 9(5):A299-304. PubMed ID: 19932199
    [Abstract] [Full Text] [Related]

  • 11. [Antibodies to various phospholipids in SLE patients with primary antiphospholipid syndrome].
    Reshetniak TM, Boĭtsekhovskaia B, Alekberova ZS, Kalashnikova LA, Mach ES, Zabek Ia.
    Klin Med (Mosk); 1999 Mar; 77(5):32-7. PubMed ID: 10394784
    [Abstract] [Full Text] [Related]

  • 12. Antiphospholipid syndrome in children.
    Avcin T.
    Curr Opin Rheumatol; 2008 Sep; 20(5):595-600. PubMed ID: 18698184
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Antiphospholipid antibodies and non-thrombotic manifestations of systemic lupus erythematosus.
    İlgen U, Yayla ME, Ateş A, Okatan İE, Yurteri EU, Torgutalp M, Keleşoğlu ABD, Turgay TM, Kınıklı G.
    Lupus; 2018 Apr; 27(4):665-669. PubMed ID: 29050535
    [Abstract] [Full Text] [Related]

  • 15. The Ped-APS Registry: the antiphospholipid syndrome in childhood.
    Avcin T, Cimaz R, Rozman B, Ped-APS Registry Collaborative Group.
    Lupus; 2009 Sep; 18(10):894-9. PubMed ID: 19671789
    [Abstract] [Full Text] [Related]

  • 16. Autoantibodies against C-reactive protein: clinical associations in systemic lupus erythematosus and primary antiphospholipid syndrome.
    Figueredo MA, Rodriguez A, Ruiz-Yagüe M, Romero M, Fernandez-Cruz A, Gomez-de la Concha E, Patiño R.
    J Rheumatol; 2006 Oct; 33(10):1980-6. PubMed ID: 17014014
    [Abstract] [Full Text] [Related]

  • 17. The effects of lupus and antiphospholipid antibody syndrome on foetal outcomes.
    Nalli C, Iodice A, Andreoli L, Lojacono A, Motta M, Fazzi E, Tincani A.
    Lupus; 2014 May; 23(6):507-17. PubMed ID: 24763535
    [Abstract] [Full Text] [Related]

  • 18. Influence of disease duration, continued followup and further antiphospholipid testing on the frequency and classification category of antiphospholipid syndrome in a cohort of patients with systemic lupus erythematosus.
    Pérez-Vázquez ME, Villa AR, Drenkard C, Cabiedes J, Alarcón-Segovia D.
    J Rheumatol; 1993 Mar; 20(3):437-42. PubMed ID: 8478848
    [Abstract] [Full Text] [Related]

  • 19. [Primary antiphospholipid syndrome evolving into systemic lupus erythematosus: a report of 3 new cases and a review of the literature].
    Blanco Y, Ramos-Casals M, García-Carrasco M, Cervera R, Font J, Ingelmo M.
    Rev Clin Esp; 1999 Sep; 199(9):586-8. PubMed ID: 10568151
    [Abstract] [Full Text] [Related]

  • 20. [Is the primary antiphospholipid syndrome a forerunner of SLE?].
    Tarr T, Muzes G, Pitlik E, Lakos G, Csépány T, Soltész P, Zeher M, Szegedi G, Kiss E.
    Orv Hetil; 2005 Jan 30; 146(5):203-7. PubMed ID: 15773587
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 41.